Time-Temperature Indicators

This video presents FDA’s recommendations for controlling Clostridium botulinum in seafood products using Time-Temperature Indicators or TTIs. The video discusses proteolytic and non-proteolytic Clostridium botulinum, conditions that may allow botulinum toxin formation, different forms of reduced oxygen packaging or ROP, and how a TTI should be used.

Time and Temperature Controls during Unrefrigerated Processing
▶︎

Time and Temperature Controls during Unrefrigerated Processing

Primary Processor Scombrotoxin Controls - Overview and Testing at Receiving
▶︎

Primary Processor Scombrotoxin Controls - Overview and Testing at Receiving

Understanding the Nutrition Facts Label, the Updated “Healthy” Claim, and Other Nutrition Claims
▶︎

Understanding the Nutrition Facts Label, the Updated “Healthy” Claim, and Other Nutrition Claims

FDA Fish and Fishery Products and Hazards Controls Guidance, 4th Edition:  Introduction and Overview
▶︎

FDA Fish and Fishery Products and Hazards Controls Guidance, 4th Edition: Introduction and Overview

FDA Grand Rounds - Pharmacovigilance in Practice: From Safety Signals to Regulatory Action
▶︎

FDA Grand Rounds - Pharmacovigilance in Practice: From Safety Signals to Regulatory Action

Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing
▶︎

Commissioner’s National Priority Voucher (CNPV) Pilot Program Public Hearing

VRBPAC -- May 28 Meeting
▶︎

VRBPAC -- May 28 Meeting

AGDD 2025 | D2S03 - Common Deficiencies and Resolutions: Complex Drug Substance/Excipients/Products
▶︎

AGDD 2025 | D2S03 - Common Deficiencies and Resolutions: Complex Drug Substance/Excipients/Products

FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers
▶︎

FDA Direct: These 9 Drugs Were Awarded National Priority Vouchers

OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products
▶︎

OTP Town Hall: Best Practices for Preparing BLA Submissions for Cell and Gene Therapy Products

AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice
▶︎

AGDD 2025 | D2S04 - Nitrosamines: Known Issues and Practical Advice

ClinicalTrials.gov: Essentials for Academic Medical Centers – Pre-recorded Training Video
▶︎

ClinicalTrials.gov: Essentials for Academic Medical Centers – Pre-recorded Training Video

Conversations on Cancer: Patient first = Project Facilitate
▶︎

Conversations on Cancer: Patient first = Project Facilitate

AGDD 2025 | D1S01 - Product-Specific Guidance for Complex Products: From Research to Standards
▶︎

AGDD 2025 | D1S01 - Product-Specific Guidance for Complex Products: From Research to Standards

AGDD 2025 | D2S05 - Workshop Closing Remarks
▶︎

AGDD 2025 | D2S05 - Workshop Closing Remarks

AGDD 2025 | D1S02 - Session 2: Q&A Discussion Panel
▶︎

AGDD 2025 | D1S02 - Session 2: Q&A Discussion Panel

AGDD 2025 | D1S01 – Session 1: Q&A Discussion Panel
▶︎

AGDD 2025 | D1S01 – Session 1: Q&A Discussion Panel

AGDD 2025 | D1S00 - Welcome and Opening Remarks
▶︎

AGDD 2025 | D1S00 - Welcome and Opening Remarks

AGDD 2025 | D2S03-1 Session 3: Q&A Discussion Panel
▶︎

AGDD 2025 | D2S03-1 Session 3: Q&A Discussion Panel

AGDD 2025 | D2S04 – Session 4: Q&A Discussion Panel
▶︎

AGDD 2025 | D2S04 – Session 4: Q&A Discussion Panel